ProPhase Labs, Inc. Class of Warrant or Right, Outstanding
ProPhase Labs, Inc. (PRPH) had Class of Warrant or Right, Outstanding of 337.19 thousand shares as of 2015-12-31, per its 10-K filed 2016-03-29.
Discontinued › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2016-03-29
- 2015-12-31: Class of Warrant or Right, Outstanding 337.19K shares.
- 2015-09-30: Class of Warrant or Right, Outstanding 1.74M shares.
- 2015-06-30: Class of Warrant or Right, Outstanding 1.74M shares.
- 2015-03-31: Class of Warrant or Right, Outstanding 1.74M shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2015-12-31 | 337.19K shares 10-K · filed 2016-03-29 |
| 2015-09-30 | 1.74M shares 10-Q · filed 2015-11-13 |
| 2015-06-30 | 1.74M shares 10-Q · filed 2015-08-12 |
| 2015-03-31 | 1.74M shares 10-Q · filed 2015-05-13 |
| 2014-12-31 | 598.61K shares 10-K · filed 2016-03-29 |
| 2014-09-30 | 1.63M shares 10-Q · filed 2015-11-13 |
| 2014-06-30 | 1.63M shares 10-Q · filed 2015-08-12 |
| 2014-03-31 | 1.64M shares 10-Q · filed 2015-05-13 |
| 2013-09-30 | 1.26M shares 10-Q · filed 2014-11-13 |
| 2013-06-30 | 1.30M shares 10-Q · filed 2014-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |